TG Therapeutics | TGTX - Ordinary Share Capital

Stock Price
29.66
Daily Change
-0.85 -2.79%
Monthly
-3.32%
Yearly
1.09%
Q1 Forecast
28.61

TG Therapeutics reported $155.21M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
Amgen USD 539M 1000K Dec/2025
Ardelyx USD 238.02M 1.13M Dec/2024
Arrowhead Research USD 135.7M 2.44M Sep/2025
Bayer EUR 982.42M 0 Sep/2025
Biogen USD 146.7M 200K Sep/2025
Corcept Therapeutics USD 105.97M 842K Dec/2025
Curis USD 59K 934K Sep/2023
Gilead Sciences USD 1.24B 1000K Dec/2025
Infinity Pharmaceuticals USD 90K 1000 Jun/2023
J&J USD 2.41B 584K Sep/2025
Karyopharm Therapeutics USD 13K 0 Sep/2024
Novartis USD 1.94B 23.4M Jun/2025
Novavax USD 1.62M 211K Sep/2024
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Puma Biotechnology USD 5K 0 Jun/2024
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025
Verastem USD 4K 1000 Sep/2024
Vertex Pharmaceuticals USD 254M 0 Dec/2025